Cargando…
Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats
CG200745 is a novel inhibitor of histone deacetylases (HDACs), initially developed for treatment of various hematological and solid cancers. Because it is water-soluble, it can be administered orally. We hypothesized that the HDAC inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in d...
Autores principales: | Lee, Eunjo, Song, Min-ji, Lee, Hae-Ahm, Kang, Seol-Hee, Kim, Mina, Yang, Eun Kyoung, Lee, Do Young, Ro, Seonggu, Cho, Joong Myung, Kim, Inkyeom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Physiological Society and The Korean Society of Pharmacology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014994/ https://www.ncbi.nlm.nih.gov/pubmed/27610034 http://dx.doi.org/10.4196/kjpp.2016.20.5.477 |
Ejemplares similares
-
Renoprotective Effect of the Histone Deacetylase Inhibitor CG200745 in DOCA-Salt Hypertensive Rats
por: Bae, Eun Hui, et al.
Publicado: (2019) -
Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease
por: Choi, Hong Sang, et al.
Publicado: (2018) -
A novel HDAC inhibitor, CG200745, inhibits pancreatic cancer cell growth and overcomes gemcitabine resistance
por: Lee, Hee Seung, et al.
Publicado: (2017) -
Histone deacetylase inhibition attenuates hepatic steatosis in rats with experimental Cushing's syndrome
por: Kim, Mina, et al.
Publicado: (2018) -
Histone deacetylase inhibitor CG200745 ameliorates high-fat diet-induced hypertension via inhibition of angiotensin II production
por: Yoon, Ga-Eun, et al.
Publicado: (2019)